Non-myeloablative allogeneic hematopoietic transplantation for patients with hematologic malignancies: 9-year single-centre experience.

AlJohani, N I; Thompson, K; Hasegawa, W; White, D; Kew, A; Couban, S.

Affiliation

AlJohani NI; Division of Hematology, Department of Medicine, Dalhousie University, and Capital District Health Authority, Halifax, NS.
Thompson K; Research Methods Unit, Department of Medicine, Centre for Clinical Research, Dalhousie University, and Capital District Health Authority, Halifax, NS.
Hasegawa W; Division of Hematology, Department of Medicine, Dalhousie University, and Capital District Health Authority, Halifax, NS.
White D; Division of Hematology, Department of Medicine, Dalhousie University, and Capital District Health Authority, Halifax, NS.
Kew A; Division of Hematology, Department of Medicine, Dalhousie University, and Capital District Health Authority, Halifax, NS.
Couban S; Division of Hematology, Department of Medicine, Dalhousie University, and Capital District Health Authority, Halifax, NS.

Curr Oncol ; 21(3): e434-40, 2014 Jun.

Article in En | MEDLINE | ID: mdl-24940103